b'<?xml version="1.0" ?>\n<!DOCTYPE PubmedArticleSet PUBLIC "-//NLM//DTD PubMedArticle, 1st January 2019//EN" "https://dtd.nlm.nih.gov/ncbi/pubmed/out/pubmed_190101.dtd">\n<PubmedArticleSet>\n<PubmedArticle>\n    <MedlineCitation Status="MEDLINE" Owner="NLM">\n        <PMID Version="1">29328418</PMID>\n        <DateCompleted>\n            <Year>2018</Year>\n            <Month>08</Month>\n            <Day>15</Day>\n        </DateCompleted>\n        <DateRevised>\n            <Year>2018</Year>\n            <Month>08</Month>\n            <Day>15</Day>\n        </DateRevised>\n        <Article PubModel="Print-Electronic">\n            <Journal>\n                <ISSN IssnType="Electronic">1791-3004</ISSN>\n                <JournalIssue CitedMedium="Internet">\n                    <Volume>17</Volume>\n                    <Issue>3</Issue>\n                    <PubDate>\n                        <Year>2018</Year>\n                        <Month>Mar</Month>\n                    </PubDate>\n                </JournalIssue>\n                <Title>Molecular medicine reports</Title>\n                <ISOAbbreviation>Mol Med Rep</ISOAbbreviation>\n            </Journal>\n            <ArticleTitle>microRNA\xe2\x80\x913941 targets IGF2 to control LPS\xe2\x80\x91induced acute pneumonia in A549 cells.</ArticleTitle>\n            <Pagination>\n                <MedlinePgn>4019-4026</MedlinePgn>\n            </Pagination>\n            <ELocationID EIdType="doi" ValidYN="Y">10.3892/mmr.2017.8369</ELocationID>\n            <Abstract>\n                <AbstractText>The present study aimed to investigate the potential roles and regulatory mechanism of microRNA (miR)-3941 in lipopolysaccharides (LPS)\xe2\x80\x91induced acute pneumonia. The expression of miR\xe2\x80\x913941 in child patients with acute pneumonia was detected and A549 cells were treated with LPS to establish the cellular model of acute pneumonia. The effects of miR\xe2\x80\x913941 in LPS\xe2\x80\x91induced cell injury were investigated by assessing cell viability, apoptosis and inflammation. In addition, the regulatory relationship between miR\xe2\x80\x913941 and insulin\xe2\x80\x91like growth factor 2 (IGF2) was explored, as well as the association between miR\xe2\x80\x913941 and the phosphatidylinositol\xe2\x80\x914,5\xe2\x80\x91bisphosphate 3\xe2\x80\x91kinase/protein kinase B (PI3K/AKT) pathway. miR\xe2\x80\x913941 was significantly down\xe2\x80\x91regulated in patients with acute pneumonia (P&lt;0.01). In the cell model of acute pneumonia, LPS treatment significantly induced cell injury via inhibiting cell viability (P&lt;0.05 or P&lt;0.01), inducing cell apoptosis (P&lt;0.01) and enhancing the production of cytokines [interleukin (IL)\xe2\x80\x916, IL\xe2\x80\x918 and tumor necrosis factor\xe2\x80\x91\xce\xb1; P&lt;0.01 or P&lt;0.001]. LPS treatment also resulted in a significantly decreased expression of miR\xe2\x80\x913941 in A549 cells (P&lt;0.01) and the overexpression of miR\xe2\x80\x913941 significantly alleviated LPS\xe2\x80\x91induced cell injury (P&lt;0.05). In addition, IGF2 was confirmed as a direct target gene of miR\xe2\x80\x913941. Knockdown of IGF2 significantly alleviated LPS\xe2\x80\x91induced cell injury (P&lt;0.05, P&lt;0.01 or P&lt;0.001), which was significantly reversed by suppression of miR\xe2\x80\x913941 (P&lt;0.05, P&lt;0.01 or P&lt;0.001). Furthermore, inhibition of miR\xe2\x80\x913941 was demonstrated to activate the PI3K/AKT pathway, which was inhibited following knockdown of IGF2. The present study indicates that miR\xe2\x80\x913941 is downregulated in child patients with acute pneumonia and that downregulation of miR\xe2\x80\x913941 may promote LPS\xe2\x80\x91induced cell injury in A549 cells via targeting IGF2 to regulate the activation of the PI3K/AKT pathway. Therefore, miR\xe2\x80\x913941 may be a potential therapeutic target for the treatment of acute pneumonia in child patients.</AbstractText>\n            </Abstract>\n            <AuthorList CompleteYN="Y">\n                <Author ValidYN="Y">\n                    <LastName>Fei</LastName>\n                    <ForeName>Shinuan</ForeName>\n                    <Initials>S</Initials>\n                    <AffiliationInfo>\n                        <Affiliation>Department of Pediatrics, Edong Healthcare Group, Huangshi Maternity and Children\'s Health Hospital, Huangshi, Hubei 435000, P.R. China.</Affiliation>\n                    </AffiliationInfo>\n                </Author>\n                <Author ValidYN="Y">\n                    <LastName>Cao</LastName>\n                    <ForeName>Lichun</ForeName>\n                    <Initials>L</Initials>\n                    <AffiliationInfo>\n                        <Affiliation>Department of Pediatrics, Huangshi Central Hospital, Affiliated Hospital of Hubei Polytechnic University, Huangshi, Hubei 435000, P.R. China.</Affiliation>\n                    </AffiliationInfo>\n                </Author>\n                <Author ValidYN="Y">\n                    <LastName>Pan</LastName>\n                    <ForeName>Liangzhi</ForeName>\n                    <Initials>L</Initials>\n                    <AffiliationInfo>\n                        <Affiliation>Department of Medical Records, Huangshi Central Hospital, Affiliated Hospital of Hubei Polytechnic University, Huangshi, Hubei 435000, P.R. China.</Affiliation>\n                    </AffiliationInfo>\n                </Author>\n            </AuthorList>\n            <Language>eng</Language>\n            <PublicationTypeList>\n                <PublicationType UI="D016428">Journal Article</PublicationType>\n            </PublicationTypeList>\n            <ArticleDate DateType="Electronic">\n                <Year>2017</Year>\n                <Month>12</Month>\n                <Day>29</Day>\n            </ArticleDate>\n        </Article>\n        <MedlineJournalInfo>\n            <Country>Greece</Country>\n            <MedlineTA>Mol Med Rep</MedlineTA>\n            <NlmUniqueID>101475259</NlmUniqueID>\n            <ISSNLinking>1791-2997</ISSNLinking>\n        </MedlineJournalInfo>\n        <ChemicalList>\n            <Chemical>\n                <RegistryNumber>0</RegistryNumber>\n                <NameOfSubstance UI="D000070416">Antagomirs</NameOfSubstance>\n            </Chemical>\n            <Chemical>\n                <RegistryNumber>0</RegistryNumber>\n                <NameOfSubstance UI="C035170">IGF2 protein, human</NameOfSubstance>\n            </Chemical>\n            <Chemical>\n                <RegistryNumber>0</RegistryNumber>\n                <NameOfSubstance UI="D008070">Lipopolysaccharides</NameOfSubstance>\n            </Chemical>\n            <Chemical>\n                <RegistryNumber>0</RegistryNumber>\n                <NameOfSubstance UI="C000617891">MIRN3941 microRNA, human</NameOfSubstance>\n            </Chemical>\n            <Chemical>\n                <RegistryNumber>0</RegistryNumber>\n                <NameOfSubstance UI="D035683">MicroRNAs</NameOfSubstance>\n            </Chemical>\n            <Chemical>\n                <RegistryNumber>0</RegistryNumber>\n                <NameOfSubstance UI="D009843">Oligoribonucleotides</NameOfSubstance>\n            </Chemical>\n            <Chemical>\n                <RegistryNumber>0</RegistryNumber>\n                <NameOfSubstance UI="D034741">RNA, Small Interfering</NameOfSubstance>\n            </Chemical>\n            <Chemical>\n                <RegistryNumber>67763-97-7</RegistryNumber>\n                <NameOfSubstance UI="D007335">Insulin-Like Growth Factor II</NameOfSubstance>\n            </Chemical>\n            <Chemical>\n                <RegistryNumber>EC 1.13.12.-</RegistryNumber>\n                <NameOfSubstance UI="D008156">Luciferases</NameOfSubstance>\n            </Chemical>\n            <Chemical>\n                <RegistryNumber>EC 2.7.1.-</RegistryNumber>\n                <NameOfSubstance UI="D019869">Phosphatidylinositol 3-Kinases</NameOfSubstance>\n            </Chemical>\n            <Chemical>\n                <RegistryNumber>EC 2.7.11.1</RegistryNumber>\n                <NameOfSubstance UI="D051057">Proto-Oncogene Proteins c-akt</NameOfSubstance>\n            </Chemical>\n        </ChemicalList>\n        <CitationSubset>IM</CitationSubset>\n        <MeshHeadingList>\n            <MeshHeading>\n                <DescriptorName UI="D000072283" MajorTopicYN="N">A549 Cells</DescriptorName>\n            </MeshHeading>\n            <MeshHeading>\n                <DescriptorName UI="D000208" MajorTopicYN="N">Acute Disease</DescriptorName>\n            </MeshHeading>\n            <MeshHeading>\n                <DescriptorName UI="D000070416" MajorTopicYN="N">Antagomirs</DescriptorName>\n                <QualifierName UI="Q000235" MajorTopicYN="N">genetics</QualifierName>\n                <QualifierName UI="Q000378" MajorTopicYN="N">metabolism</QualifierName>\n            </MeshHeading>\n            <MeshHeading>\n                <DescriptorName UI="D017209" MajorTopicYN="N">Apoptosis</DescriptorName>\n                <QualifierName UI="Q000187" MajorTopicYN="N">drug effects</QualifierName>\n            </MeshHeading>\n            <MeshHeading>\n                <DescriptorName UI="D001483" MajorTopicYN="N">Base Sequence</DescriptorName>\n            </MeshHeading>\n            <MeshHeading>\n                <DescriptorName UI="D001665" MajorTopicYN="N">Binding Sites</DescriptorName>\n            </MeshHeading>\n            <MeshHeading>\n                <DescriptorName UI="D002470" MajorTopicYN="N">Cell Survival</DescriptorName>\n                <QualifierName UI="Q000187" MajorTopicYN="N">drug effects</QualifierName>\n            </MeshHeading>\n            <MeshHeading>\n                <DescriptorName UI="D002648" MajorTopicYN="N">Child</DescriptorName>\n            </MeshHeading>\n            <MeshHeading>\n                <DescriptorName UI="D002675" MajorTopicYN="N">Child, Preschool</DescriptorName>\n            </MeshHeading>\n            <MeshHeading>\n                <DescriptorName UI="D005260" MajorTopicYN="N">Female</DescriptorName>\n            </MeshHeading>\n            <MeshHeading>\n                <DescriptorName UI="D005786" MajorTopicYN="Y">Gene Expression Regulation</DescriptorName>\n            </MeshHeading>\n            <MeshHeading>\n                <DescriptorName UI="D017930" MajorTopicYN="N">Genes, Reporter</DescriptorName>\n            </MeshHeading>\n            <MeshHeading>\n                <DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName>\n            </MeshHeading>\n            <MeshHeading>\n                <DescriptorName UI="D007223" MajorTopicYN="N">Infant</DescriptorName>\n            </MeshHeading>\n            <MeshHeading>\n                <DescriptorName UI="D007335" MajorTopicYN="N">Insulin-Like Growth Factor II</DescriptorName>\n                <QualifierName UI="Q000037" MajorTopicYN="N">antagonists &amp; inhibitors</QualifierName>\n                <QualifierName UI="Q000235" MajorTopicYN="Y">genetics</QualifierName>\n                <QualifierName UI="Q000378" MajorTopicYN="N">metabolism</QualifierName>\n            </MeshHeading>\n            <MeshHeading>\n                <DescriptorName UI="D008070" MajorTopicYN="N">Lipopolysaccharides</DescriptorName>\n                <QualifierName UI="Q000494" MajorTopicYN="N">pharmacology</QualifierName>\n            </MeshHeading>\n            <MeshHeading>\n                <DescriptorName UI="D008156" MajorTopicYN="N">Luciferases</DescriptorName>\n                <QualifierName UI="Q000235" MajorTopicYN="N">genetics</QualifierName>\n                <QualifierName UI="Q000378" MajorTopicYN="N">metabolism</QualifierName>\n            </MeshHeading>\n            <MeshHeading>\n                <DescriptorName UI="D008297" MajorTopicYN="N">Male</DescriptorName>\n            </MeshHeading>\n            <MeshHeading>\n                <DescriptorName UI="D035683" MajorTopicYN="N">MicroRNAs</DescriptorName>\n                <QualifierName UI="Q000819" MajorTopicYN="N">agonists</QualifierName>\n                <QualifierName UI="Q000037" MajorTopicYN="N">antagonists &amp; inhibitors</QualifierName>\n                <QualifierName UI="Q000235" MajorTopicYN="Y">genetics</QualifierName>\n                <QualifierName UI="Q000378" MajorTopicYN="N">metabolism</QualifierName>\n            </MeshHeading>\n            <MeshHeading>\n                <DescriptorName UI="D009843" MajorTopicYN="N">Oligoribonucleotides</DescriptorName>\n                <QualifierName UI="Q000235" MajorTopicYN="N">genetics</QualifierName>\n                <QualifierName UI="Q000378" MajorTopicYN="N">metabolism</QualifierName>\n            </MeshHeading>\n            <MeshHeading>\n                <DescriptorName UI="D019869" MajorTopicYN="N">Phosphatidylinositol 3-Kinases</DescriptorName>\n                <QualifierName UI="Q000235" MajorTopicYN="Y">genetics</QualifierName>\n                <QualifierName UI="Q000378" MajorTopicYN="N">metabolism</QualifierName>\n            </MeshHeading>\n            <MeshHeading>\n                <DescriptorName UI="D011014" MajorTopicYN="N">Pneumonia</DescriptorName>\n                <QualifierName UI="Q000235" MajorTopicYN="Y">genetics</QualifierName>\n                <QualifierName UI="Q000378" MajorTopicYN="N">metabolism</QualifierName>\n                <QualifierName UI="Q000473" MajorTopicYN="N">pathology</QualifierName>\n            </MeshHeading>\n            <MeshHeading>\n                <DescriptorName UI="D051057" MajorTopicYN="N">Proto-Oncogene Proteins c-akt</DescriptorName>\n                <QualifierName UI="Q000235" MajorTopicYN="Y">genetics</QualifierName>\n                <QualifierName UI="Q000378" MajorTopicYN="N">metabolism</QualifierName>\n            </MeshHeading>\n            <MeshHeading>\n                <DescriptorName UI="D034741" MajorTopicYN="N">RNA, Small Interfering</DescriptorName>\n                <QualifierName UI="Q000235" MajorTopicYN="N">genetics</QualifierName>\n                <QualifierName UI="Q000378" MajorTopicYN="N">metabolism</QualifierName>\n            </MeshHeading>\n            <MeshHeading>\n                <DescriptorName UI="D015398" MajorTopicYN="N">Signal Transduction</DescriptorName>\n            </MeshHeading>\n        </MeshHeadingList>\n    </MedlineCitation>\n    <PubmedData>\n        <History>\n            <PubMedPubDate PubStatus="received">\n                <Year>2017</Year>\n                <Month>04</Month>\n                <Day>27</Day>\n            </PubMedPubDate>\n            <PubMedPubDate PubStatus="accepted">\n                <Year>2017</Year>\n                <Month>11</Month>\n                <Day>02</Day>\n            </PubMedPubDate>\n            <PubMedPubDate PubStatus="pubmed">\n                <Year>2018</Year>\n                <Month>1</Month>\n                <Day>13</Day>\n                <Hour>6</Hour>\n                <Minute>0</Minute>\n            </PubMedPubDate>\n            <PubMedPubDate PubStatus="medline">\n                <Year>2018</Year>\n                <Month>8</Month>\n                <Day>16</Day>\n                <Hour>6</Hour>\n                <Minute>0</Minute>\n            </PubMedPubDate>\n            <PubMedPubDate PubStatus="entrez">\n                <Year>2018</Year>\n                <Month>1</Month>\n                <Day>13</Day>\n                <Hour>6</Hour>\n                <Minute>0</Minute>\n            </PubMedPubDate>\n        </History>\n        <PublicationStatus>ppublish</PublicationStatus>\n        <ArticleIdList>\n            <ArticleId IdType="pubmed">29328418</ArticleId>\n            <ArticleId IdType="doi">10.3892/mmr.2017.8369</ArticleId>\n        </ArticleIdList>\n    </PubmedData>\n</PubmedArticle>\n\n</PubmedArticleSet>'